CUMBERLAND PHARMACEUTICALS INC (CPIX) Insider Trading & SEC Filings
Last SEC filing
CUMBERLAND PHARMACEUTICALS INC (CPIX) - no SEC Form 4 insider filings recorded in the last 90 days. 3 Form 8-K material event filings were reported by CPIX in the last 90 days. InsiderAlpha tracks every CPIX SEC filing - Form 4, Form 144, and 8-K - in real time, including Rule 10b5-1 plan detection.
About CUMBERLAND PHARMACEUTICALS INC (CPIX)
CUMBERLAND PHARMACEUTICALS INC trades under the ticker CPIX. InsiderAlpha tracks 63 primary SEC Form 4 filings from 10 reporting insiders for CPIX since 2024, sourced directly from SEC EDGAR.
| Sector | Health Care insider trading |
|---|---|
| SIC classification | Pharmaceutical Preparations (SIC 2834) |
| SEC CIK | 0001087294 |
90-Day SEC Filing Activity
| Form 8-K filings (90d) | 3 |
|---|---|
| Latest Form 4 filing | 2026-03-20 |
Recent CPIX Insider Transactions (Form 4)
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Joseph C. Galante | Director | A - Grant or award | 1.8K | $2.80 | $5K | SEC | |
| Kenneth Krogulski | Director | A - Grant or award | 1.8K | $2.80 | $5K | SEC | |
| Kenneth Krogulski | Director | A - Grant or award | 4.0K | $2.80 | $11K | SEC | |
| Martin S. Brown Jr. | Director | A - Grant or award | 1.8K | $2.80 | $5K | SEC | |
| Caroline Young | Director | A - Grant or award | 1.8K | $2.80 | $5K | SEC | |
| James Jones | Director | A - Grant or award | 1.8K | $2.80 | $5K | SEC | |
| A. J. Kazimi | Chairman and CEO | F - Tax withholding / forfeiture | 5.8K | $3.06 | $18K | SEC | |
| A. J. Kazimi | Chairman and CEO | J - Other acquisition / disposition [10b5-1] | 18 | $2.41 | $43 | SEC | |
| Caroline Young | Director | J - Other acquisition / disposition [10b5-1] | 4 | $2.41 | $10 | SEC | |
| James Jones | Director | J - Other acquisition / disposition [10b5-1] | 18 | $2.41 | $43 | SEC | |
| Kenneth Krogulski | Director | J - Other acquisition / disposition [10b5-1] | 124 | $2.41 | $299 | SEC | |
| A. J. Kazimi | Chairman and CEO | J - Other acquisition / disposition [10b5-1] | 18 | $2.17 | $39 | SEC | |
| Kenneth Krogulski | Director | J - Other acquisition / disposition [10b5-1] | 124 | $2.17 | $269 | SEC | |
| Caroline Young | Director | J - Other acquisition / disposition [10b5-1] | 4 | $2.17 | $9 | SEC | |
| James Jones | Director | J - Other acquisition / disposition [10b5-1] | 18 | $2.17 | $39 | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for CUMBERLAND PHARMACEUTICALS INC (CPIX). Updated in real time as new filings are submitted to the SEC.
Recent CPIX Form 8-K Material Events
- - Item 8.01 [SEC]
- - Item 1.01, 1.02, 2.01, 5.02, 8.01, 9.01 [SEC]
- - Item 5.07 [SEC]
- - Item 2.02, 9.01 [SEC]
- - Item 5.07 · Other · neutral [SEC]
Cumberland Pharmaceuticals held its annual shareholder meeting on April 21, 2026, where shareholders voted to approve the election of two Class I directors (Kenneth J. Krogulski and Caroline R. Young), ratify the appointment of Carr, Riggs & Ingram LLC as independent auditor, and
Recent Insider Filings
- - Martin S. Brown Jr. (Director)
- - Joseph C. Galante (Director)
- - James Jones (Director)
- - Kenneth Krogulski (Director)
- - Caroline Young (Director)
Form 4 Transaction Code Reference
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in CPIX insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
CPIX Insider Trading - FAQ
- What is the latest insider trade for CPIX?
- CUMBERLAND PHARMACEUTICALS INC (CPIX) had 0 insider filings in the last 90 days, with the most recent on 2026-03-20. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
- How many insiders are buying CPIX stock?
- 0 insider purchases of CPIX were filed in the last 90 days.
- How many insiders are selling CPIX stock?
- 0 insider sales of CPIX were filed in the last 90 days.
- Where can I see CPIX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
- This page tracks CPIX Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care Companies with Insider Activity
Other companies in the InsiderAlpha index with a significant SEC Form 4 insider-trading footprint:
- $CRSP CRISPR Therapeutics AG
- $CTTH CTT PHARMACEUTICAL HOLDINGS, INC.
- $CV CapsoVision, Inc
- $CVKD Cadrenal Therapeutics, Inc.
- $CVM CEL SCI CORP
- $DMAC DiaMedica Therapeutics Inc.
- $EDGM Edgemode, Inc.
- $ERNA Ernexa Therapeutics Inc.
- $ETNB 89bio, Inc.
- $EWTX Edgewise Therapeutics, Inc.
Related Companies - Recent Insider Activity
- UNITED THERAPEUTICS Corp (UTHR)
- Liquidia Corp (LQDA)
- BeOne Medicines Ltd. (ONC)
- PERRIGO Co plc (PRGO)
- Processa Pharmaceuticals, Inc. (PCSA)
- Nuvalent, Inc. (NUVL)
- CYTOKINETICS INC (CYTK)
- Elanco Animal Health Inc (ELAN)
- Avalo Therapeutics, Inc. (AVTX)
- NATURES SUNSHINE PRODUCTS INC (NATR)
Learn More
- What is SEC Form 4?
- How to read insider buying signals
- Rule 10b5-1 trading plans explained
- The cluster buying signal
Open the live CPIX dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.